[{"Assets_0_Q3_USD":763117000.0,"CommonStockSharesOutstanding_0_Q3_shares":89310684.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-206245000.0,"NetIncomeLoss_1_Q3_USD":-60682000.0,"NetIncomeLoss_3_Q3_USD":-201349000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":89245000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":82907000.0,"StockholdersEquity_0_Q3_USD":304041000.0,"Ticker":"INSM","CIK":"1104506","name":"INSMED INC","OfficialName":"Insmed Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2980602494.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191030"}]